Literature DB >> 7494283

Expression of the polyomavirus minor capsid proteins VP2 and VP3 in Escherichia coli: in vitro interactions with recombinant VP1 capsomeres.

S E Delos1, T P Cripe, A D Leavitt, H Greisman, R L Garcea.   

Abstract

The polyomavirus VP2 and VP3 capsid proteins were expressed in Escherichia coli. The majority of the expressed proteins were in an insoluble fraction, and they were extracted and initially purified in 8 M urea before renaturation. Soluble VP2 and VP3 were mixed with purified recombinant VP1 capsomeres, and their interactions were assayed by immunoprecipitation and ion-exchange chromatography. Coimmunoprecipitation could be demonstrated with antibodies to either VP1 or VP2/VP3. Mixing recombinant VP1 with VP2 and VP3 modified the recognition of VP1 by domain-specific antipeptide antibodies and altered the chromatographic behavior of the individual proteins. Similar results were observed when a truncated VP1 protein, delta NCOVP1, with 62 amino acids deleted from the carboxy terminus was mixed with VP2/VP3. After the mixing, equilibrium dissociation constants for their binding to either VP1 or delta NCOVP1 were determined to be 0.37 +/- 0.23 microM for VP2 and 0.18 +/- 0.21 microM for VP3. These studies demonstrate that the recombinant VP2 and VP3 proteins interact with VP1 to affect the biochemical properties of VP1 capsomeres and to change the epitope accessibility of VP1 pentamers. These changes may reflect conformational alterations in VP1 capsomeres which are necessary for viral genome encapsidation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494283      PMCID: PMC189715     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Vp1 affects intracellular localization of Vp3 polypeptide during simian virus 40 infection.

Authors:  H Kasamatsu; A Nehorayan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

2.  Chromatographic separation of the polyoma virus proteins and renaturation of the isolated VP1 major capsid protein.

Authors:  J N Brady; R A Consigli
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

3.  Intermolecular disulfide bonds: an important structural feature of the polyoma virus capsid.

Authors:  G Walter; W Deppert
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

4.  Deficiency in histone acetylation in nontransforming host range mutants of polyoma virus.

Authors:  B S Schaffhausen; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

5.  Subunit interactions in polyoma virus structure.

Authors:  D Etchison; G Walter
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

6.  Interactions among the major and minor coat proteins of polyomavirus.

Authors:  D H Barouch; S C Harrison
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

7.  Characterization of the DNA binding properties of polyomavirus capsid protein.

Authors:  D Chang; X Cai; R A Consigli
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

8.  Characterization of components released by alkali disruption of simian virus 40.

Authors:  G Christiansen; T Landers; J Griffith; P Berg
Journal:  J Virol       Date:  1977-03       Impact factor: 5.103

9.  Polyomavirus VP1 phosphorylation: coexpression with the VP2 capsid protein modulates VP1 phosphorylation in Sf9 insect cells.

Authors:  M Li; S E Delos; L Montross; R L Garcea
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

10.  Functional complementation of nuclear targeting-defective mutants of simian virus 40 structural proteins.

Authors:  N Ishii; A Nakanishi; M Yamada; M H Macalalad; H Kasamatsu
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more
  9 in total

1.  Identification of amino acid residues within simian virus 40 capsid proteins Vp1, Vp2, and Vp3 that are required for their interaction and for viral infection.

Authors:  Akira Nakanishi; Akiko Nakamura; Robert Liddington; Harumi Kasamatsu
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Analysis of capsid formation of human polyomavirus JC (Tokyo-1 strain) by a eukaryotic expression system: splicing of late RNAs, translation and nuclear transport of major capsid protein VP1, and capsid assembly.

Authors:  Y Shishido-Hara; Y Hara; T Larson; K Yasui; K Nagashima; G L Stoner
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  In vivo and in vitro association of hsc70 with polyomavirus capsid proteins.

Authors:  T P Cripe; S E Delos; P A Estes; R L Garcea
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

4.  Polyomavirus major capsid protein VP1 is capable of packaging cellular DNA when expressed in the baculovirus system.

Authors:  E T Gillock; S Rottinghaus; D Chang; X Cai; S A Smiley; K An; R A Consigli
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly.

Authors:  M Li; T P Cripe; P A Estes; M K Lyon; R C Rose; R L Garcea
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Minor capsid proteins of simian virus 40 are dispensable for nucleocapsid assembly and cell entry but are required for nuclear entry of the viral genome.

Authors:  Akira Nakanishi; Noriko Itoh; Peggy P Li; Hiroshi Handa; Robert C Liddington; Harumi Kasamatsu
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

7.  L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation.

Authors:  M M Okun; P M Day; H L Greenstone; F P Booy; D R Lowy; J T Schiller; R B Roden
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

8.  Major and minor capsid proteins of human polyomavirus JC cooperatively accumulate to nuclear domain 10 for assembly into virions.

Authors:  Yukiko Shishido-Hara; Shizuko Ichinose; Kayoko Higuchi; Yoshinobu Hara; Kotaro Yasui
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Adjuvanting a subunit COVID-19 vaccine to induce protective immunity.

Authors:  Prabhu S Arunachalam; Alexandra C Walls; Nadia Golden; Caroline Atyeo; Stephanie Fischinger; Chunfeng Li; Pyone Aye; Mary Jane Navarro; Lilin Lai; Venkata Viswanadh Edara; Katharina Röltgen; Kenneth Rogers; Lisa Shirreff; Douglas E Ferrell; Samuel Wrenn; Deleah Pettie; John C Kraft; Marcos C Miranda; Elizabeth Kepl; Claire Sydeman; Natalie Brunette; Michael Murphy; Brooke Fiala; Lauren Carter; Alexander G White; Meera Trisal; Ching-Lin Hsieh; Kasi Russell-Lodrigue; Christopher Monjure; Jason Dufour; Skye Spencer; Lara Doyle-Meyers; Rudolph P Bohm; Nicholas J Maness; Chad Roy; Jessica A Plante; Kenneth S Plante; Alex Zhu; Matthew J Gorman; Sally Shin; Xiaoying Shen; Jane Fontenot; Shakti Gupta; Derek T O'Hagan; Robbert Van Der Most; Rino Rappuoli; Robert L Coffman; David Novack; Jason S McLellan; Shankar Subramaniam; David Montefiori; Scott D Boyd; JoAnne L Flynn; Galit Alter; Francois Villinger; Harry Kleanthous; Jay Rappaport; Mehul S Suthar; Neil P King; David Veesler; Bali Pulendran
Journal:  Nature       Date:  2021-04-19       Impact factor: 49.962

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.